- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01984450
A Study to Compare Two Techniques for Articular Cartilage Repair:ACIC Vs. MCIC
A Study to Compare Two Articular Cartilage Repair Techniques in the Knee Joint: Autologous Collagen Induced Chondrogenesis (ACIC) Vs. Mesenchymal Cell Induced Chondrogenesis (MCIC).
Study Title: A study to compare two articular cartilage repair techniques in the knee joint: Autologous Collagen Induced Chondrogenesis (ACIC) Vs. Mesenchymal Cell Induced Chondrogenesis (MCIC).
Study hypothesis: We start with the hypothesis that both treatments are equally effective.
Trial Design: This is a prospective study. The participating patients will be divided into two groups, each group receiving either one of the treatment modalities. This study will not be randomised or blinded. Both procedures will be done at the Spire Alexandra Hospital by Professor A. A Shetty, who is one half of the team that devised both techniques.
Trial Participants: All participants will be from patients attending Professor Shetty's clinic at the Spire Alexandra Hospital.
Planned Sample Size: 50 patients in each arm.
Follow-up duration: The participating patients will be followed up at 2 weeks, 6 weeks, 3 months, 6 months, 1 year and 2 years following the surgery by visits to the clinic and assessed clinically. The surgical outcomes will be measured by by IKDC, KOOS and Lysholm scores; cartilage growth will be measured by the MOCART score.
Planned Trial Period: Two to three years
Primary Objective: To establish superiority, if any, of either procedure over the other.
Primary Endpoint: At the end of the 2 year follow up for all participating patients.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
BACKGROUND: Articular cartilage repair in the knee is aimed at young patients with area(s) of cartilage loss and no deformity of the knee. These patients aren't indicated for a knee replacement. Articular cartilage repair leads to improvement of symptoms of pain, locking and function. Traditionally, articular cartilage repair has always involved exposing the entire knee joint with an arthrotomy. This, though effective, would lead to a large scar, longer hospital stay, longer rehabilitation and its associated complications. Also, the use of Bone Marrow Aspirate Cells (BMAC) for the purpose of cartilage repair has long been debated with both sides having valid arguments and good surgical results.
RATIONALE: Both procedures in this study are performed in one stage, arthroscopically and as day case procedures, which offers minimal scarring and quicker recovery. This automatically confers a significant advantage over the traditional surgical techniques.
To correct the articular cartilage defect, the ACIC method requires autologous Atellocollagen (a protein based structure), while the MCIC method uses concentrated BMAC taken from the patient's iliac crest.
Both procedures have shown encouraging results in terms of pain relief, cartilage growth and improved function. Since one technique utilises a protein based reagent and the other involves mesenchymal cells, this study aims to ascertain if either technique is superior to the other.
STUDY DESIGN: This study aims to compare two techniques of articular cartilage repair in the knee, namely Autologous Collagen Induced Chondrogenesis (ACIC) and Mesenchymal Cell Induced Chondrogenesis (MCIC). The principal objective of is to ascertain and assess the superiority, if any, of either surgical technique over the other. The superiority will be assessed with by the certain scoring systems (IKDC, KOOS, Lysholm and MOCART) measured pre- and post-operatively.
Depending on which procedure the patient chooses to have, they will be allotted to either the ACIC or the MCIC group. The patient is followed up in the clinic at the Spire Alexandra Hospital at 2 weeks, 6 weeks, 3 months, 6 months, 1 year and 2 years following the surgery and their progress is documented by questionnaires and clinical examination. MRI scans are done at one and two years to assess the extent of cartilage growth.
SURGICAL TECHNIQUES
Autologous Collagen Induced Chondrogenesis (ACIC):
ACIC is a single stage arthroscopic procedure. It is done as a day case? procedure and the patient is admitted a few hours before the procedure. The anaesthetic method depends is the Anaesthesiologist's prerogative and depends on the patient's general health. Under sterile conditions in an operating theatre, the arthroscopic instruments are introduced inside the knee joint. As assessed previously by MRI scans, the area of cartilage defect is debrided by curettage, shaving and burring and then microfractured. The ACIC method utilises autologous Atellocollagen, a protein based structure, mixed with thrombin and fibrinogen to form a gel which coats the area with a cartilage defect. The entry ports are then closed and the knee is covered with a sterile dressing. The patient is transferred to the surgical recovery ward and, when medically stable, then transferred to their room on the ward.
After discharge from the hospital, the patient is advised partial weight bearing on the operated leg for 6 weeks after the surgery. They also undergo 5 sessions of physiotherapy. Surgical clips and sutures are removed at 2 weeks following the surgery.
Mesenchymal Cell Induced Chondrogenesis (MCIC):
MCIC is a single stage arthroscopic procedure. It is done as a day case? procedure and the patient is admitted a few hours before the procedure. The anaesthetic method depends is the Anaesthesiologist's prerogative and depends on the patient's general health. Under sterile conditions in an operating theatre, the arthroscopic instruments are introduced inside the knee joint. As assessed previously by MRI scans, the area of cartilage defect is debrided by curettage, shaving and burring and then microfractured. The MCIC method involves aspiration of Bone Marrow Aspirate Cells (BMAC) from the patient's iliac crest (hip bone) and concentrating the cells by centrifugation in the operation theatre itself. The BMAC are then mixed with thrombin and fibrinogen to form a gel which coats the area with a cartilage defect.
After discharge from the hospital, the patient is advised partial weight bearing on the operated leg for 6 weeks after the surgery. They also undergo 5 sessions of physiotherapy. Surgical clips and sutures are removed at 2 weeks following the surgery.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Asode A Shetty, MD, PhD, MCh, FRCS
- Phone Number: 01634 662813
- Email: aashetty@hotmail.com
Study Locations
-
-
Kent
-
Walderslade, Kent, United Kingdom, ME5 9PG
- Kent Knee Unit
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participant is willing and able to give informed consent for participation in the study.
- Male or Female, aged 18 years to 65 years.
- Diagnosed with articular cartilage defect in the knee (ICRS/Outerbridge grade III/IV cartilage lesions as assessed on MRI scan).
- No other significant medical co-morbidities, as assessed by pre-operatively, that could interfere with surgery results of trial eg. Hypertension, COPD etc.
- Participant has clinically acceptable laboratory and ECG tests at pre-assessment clinic.
- Able (in the Investigators opinion) and willing to comply with all study requirements.
- Up to 3 lesions of sizes 2-8 square cm.
Exclusion Criteria:
- Generalized and/or inflammatory arthritis
- Active joint inflammation
- More than 5 degrees of varus or valgus deformity
- Age below 18 and over 65 years
- More than 4 lesions
- Lesions more than 8 square cm.
- Significant co-morbidities or classified as ASA grade 3/4
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: ACIC
The patients in this group will be treated by the ACIC technique, which uses autologous collagen to regenerate articular cartilage.
ACIC is a single stage arthroscopic procedure.
It is done as a day case procedure.
The cartilage defect is debrided and implanted with a collagen + fibrin gel mixture under CO2 insufflation.
|
Autologous Collagen Induced Chondrogenesis (ACIC): ACIC is a single stage arthroscopic procedure. It is done as a day case procedure. The cartilage defect is debrided and implanted with a collagen + fibrin gel mixture under CO2 insufflation. |
Active Comparator: MCIC
The patients in this group will be treated by the MCIC technique, which uses concentrated BMAC to regenerate articular cartilage.
MCIC is a single stage arthroscopic procedure.
It is done as a day case procedure.
BMAC is harvested intraoperatively and concentrated.
It is then mixed with a fibrin gel and implanted under CO2 insufflation.
|
Mesenchymal Cell Induced Chondrogenesis (MCIC): MCIC is a single stage arthroscopic procedure. It is done as a day case procedure. BMAC is harvested intraoperatively and concentrated. It is then mixed with a fibrin gel and implanted under CO2 insufflation. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical outcome
Time Frame: 2 years
|
This study aims to compare two techniques of articular cartilage repair in the knee, namely Autologous Collagen Induced Chondrogenesis (ACIC) and Mesenchymal Cell Induced Chondrogenesis (MCIC).
The principal objective of is to ascertain and assess the superiority, if any, of either surgical technique over the other.
The superiority will be assessed with by the IKDC score measured pre- and post-operatively
|
2 years
|
Radiological outcome
Time Frame: 2 years
|
This study aims to compare two techniques of articular cartilage repair in the knee, namely Autologous Collagen Induced Chondrogenesis (ACIC) and Mesenchymal Cell Induced Chondrogenesis (MCIC).
The principal objective of is to ascertain and assess the superiority, if any, of either surgical technique over the other.
The superiority will be assessed with by the MOCART score measured pre- and post-operatively
|
2 years
|
Clinical outcome
Time Frame: 2 years
|
This study aims to compare two techniques of articular cartilage repair in the knee, namely Autologous Collagen Induced Chondrogenesis (ACIC) and Mesenchymal Cell Induced Chondrogenesis (MCIC).
The principal objective of is to ascertain and assess the superiority, if any, of either surgical technique over the other.
The superiority will be assessed with by the KOOS score measured pre- and post-operatively
|
2 years
|
Clinical outcome
Time Frame: 2 years
|
This study aims to compare two techniques of articular cartilage repair in the knee, namely Autologous Collagen Induced Chondrogenesis (ACIC) and Mesenchymal Cell Induced Chondrogenesis (MCIC).
The principal objective of is to ascertain and assess the superiority, if any, of either surgical technique over the other.
The superiority will be assessed with by the Lysholm score measured pre- and post-operatively
|
2 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Asode A Shetty, MD, PhD, MCh, FRCS, Canterbury Christ Church University
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- SKRF 002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Articular Cartilage Defect
-
Biosolution Co., Ltd.Active, not recruitingArticular Cartilage Defect | Articular Cartilage DegenerationKorea, Republic of
-
The Third Affiliated Hospital of Southern Medical...RecruitingArticular Cartilage DefectChina
-
Biosolution Co., Ltd.RecruitingArticular Cartilage Defect | Articular Cartilage DegenerationUnited States
-
Sewon Cellontech Co., Ltd.UnknownDefect of Articular Cartilage | Articular Cartilage Disorder of Knee | Degeneration; Articular Cartilage, KneeKorea, Republic of
-
Oligo Medic Pty LtdMobius Medical Pty Ltd.RecruitingChondral Defect | Articular Cartilage Disorder of Knee | Articular Cartilage DefectAustralia, Canada
-
Zimmer Orthobiologics, Inc.TerminatedDefect of Articular Cartilage | Articular Cartilage Disorder | Degeneration; Articular Cartilage | Chronic Cartilage Injury | Acute Cartilage InjuryUnited States
-
Vericel CorporationRecruitingChondral Defect | Articular Cartilage Disorder of Knee | Articular Cartilage Defect | Osteochondritis Dissecans (OCD)United States
-
ISTO Technologies, Inc.TerminatedDefect of Articular Cartilage | Articular Cartilage Disorder | Degeneration; Articular Cartilage | Chronic Cartilage Injury | Acute Cartilage InjuryUnited States
-
Centre Hospitalier Universitaire VaudoisRecruitingChondral Defect | Articular Cartilage Defect | OsteochondritisSwitzerland
-
BioPoly LLCCompletedCartilage Injury | Defect of Articular Cartilage | Cartilage DamageUnited Kingdom